Axcella Health Reports First Quarter 2019 Financial Results and Provides Company Update
June 20, 2019 17:10 ET
|
Axcella Health
Successfully completed initial public offering, raising $71.4 million in gross proceedsPresented data on AXA1665 and AXA1125 at two leading medical conferencesIdentified drug development path for...
Axcella Health Announces Closing of Initial Public Offering
May 13, 2019 17:30 ET
|
Axcella Health
CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated...
Axcella Health Announces Pricing of Initial Public Offering
May 08, 2019 20:40 ET
|
Axcella Health
CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated...